Nayax CEO exercises options on 235K shares

Q: How many Nayax Ltd. (NYAX) shares were involved in Yair Nechmad’s Form 4 filing?

The Form 4 shows option exercises for a total of 235,605 ordinary shares of Nayax Ltd., split across four derivative transactions and four corresponding acquisitions of ordinary shares on August 26, 2026.

Q: What was the exercise price for Yair Nechmad’s NYAX stock options?

The reported exercise price for the options was $33.7079 per share, with a footnote stating that the exercise price is denominated in New Israeli Shekels and the U.S. dollar amount reflects the exchange rate on the grant date.

Q: Were any Nayax Ltd. (NYAX) shares sold by Yair Nechmad in this Form 4?

No. The filing reports only option exercises and corresponding acquisitions of ordinary shares. There are no sale transactions reported; non-derivative entries are coded as acquired, not disposed.

Q: Does the NYAX Form 4 indicate a Rule 10b5-1 trading plan for Yair Nechmad’s transactions?

The document-level Rule 10b5-1 checkbox is not checked (aff_10b5_one is false), and the footnotes do not state that these transactions were made pursuant to a Rule 10b5-1 trading plan.

Nayax Ltd. (NYAX) reported that CEO, Co Founder & Chairman Yair Nechmad exercised stock options into ordinary shares on August 26, 2026.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Nayax Ltd. (NYAX) reported that CEO, Co Founder & Chairman Yair Nechmad exercised stock options into ordinary shares on August 26, 2026. He exercised options covering 235,605 ordinary shares at an exercise price of $33.7079 per share (U.S. dollar amount reflecting a New Israeli Shekel–denominated grant). The options exercised were originally granted in 2022 and 2025 with expirations in 2027 and 2030, respectively. The filing does not state his total share holdings after these transactions.

Insider Trade Summary

235,605 shares exercised/converted

Exercise 8 txns

Insider Nechmad Yair

Role CEO, Co Founder & Chairman

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) ^{F1, F2}	75,000	$0.00	$0.00
Exercise	Stock Option (Right to Buy) ^{F1, F2}	75,000	$0.00	$0.00
Exercise	Stock Option (Right to Buy) ^{F1, F2}	70,000	$0.00	$0.00
Exercise	Stock Option (Right to Buy) ^{F1, F2}	15,605	$0.00	$0.00
Exercise	Ordinary Shares ^{F3, F4}	75,000	$33.7079	$2.53M
Exercise	Ordinary Shares ^{F3, F4}	75,000	$33.7079	$2.53M
Exercise	Ordinary Shares ^{F3, F4}	70,000	$33.7079	$2.36M
Exercise	Ordinary Shares ^{F3, F4}	15,605	$33.7079	$526K

Holdings After Transaction: Stock Option (Right to Buy) — 0 contracts (Direct); Ordinary Shares — 7,329,047 shares (Direct)

Footnotes (4)

F1. The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.
F2. The options reported herein were exercised on the date reported, and the shares acquired upon exercise are reported in Table I .
F3. The shares were acquired upon the exercise of stock options
F4. The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.

Key Figures

Options exercised: 235,605 shares Exercise price: $33.7079 per share Derivative transaction count: 4 transactions +2 more

5 metrics

Options exercised 235,605 shares Total underlying ordinary shares from four derivative exercises on August 26, 2026

Exercise price $33.7079 per share Exercise price for the stock options, denominated in New Israeli Shekels with U.S. dollar amount based on grant-date exchange rate

Derivative transaction count 4 transactions Number of stock option exercises (code M) reported in derivative securities

Non-derivative acquisition count 4 transactions Number of ordinary share acquisitions corresponding to option exercises on August 26, 2026

Option expiration dates March 8, 2027; March 4, 2030 Expiration dates for the option series exercised

Key Terms

Stock Option (Right to Buy), Ordinary Shares, exercise price, New Israeli Shekels

4 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

Ordinary Shares financial

"underlying_security_title: "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

exercise price financial

"The exercise price is denominated in New Israeli Shekels."

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

New Israeli Shekels financial

"denominated in New Israeli Shekels. The U.S. dollar amount reported"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did NYAX report for Yair Nechmad on August 26, 2026?

Nayax Ltd. (NYAX) reported that Yair Nechmad exercised stock options covering 235,605 ordinary shares on August 26, 2026, acquiring the same number of ordinary shares through option exercises rather than open-market purchases or sales.

How many Nayax Ltd. (NYAX) shares were involved in Yair Nechmad’s Form 4 filing?

The Form 4 shows option exercises for a total of 235,605 ordinary shares of Nayax Ltd., split across four derivative transactions and four corresponding acquisitions of ordinary shares on August 26, 2026.

What was the exercise price for Yair Nechmad’s NYAX stock options?

The reported exercise price for the options was $33.7079 per share, with a footnote stating that the exercise price is denominated in New Israeli Shekels and the U.S. dollar amount reflects the exchange rate on the grant date.

Were any Nayax Ltd. (NYAX) shares sold by Yair Nechmad in this Form 4?

No. The filing reports only option exercises and corresponding acquisitions of ordinary shares. There are no sale transactions reported; non-derivative entries are coded as acquired, not disposed.

What are the grant and expiration dates of the NYAX options exercised by Yair Nechmad?

The options exercised on August 26, 2026 include grants with exercise dates of March 8, 2022 expiring on March 8, 2027, and grants with exercise dates of March 4, 2025 expiring on March 4, 2030.

Does the NYAX Form 4 indicate a Rule 10b5-1 trading plan for Yair Nechmad’s transactions?

The document-level Rule 10b5-1 checkbox is not checked (aff_10b5_one is false), and the footnotes do not state that these transactions were made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 08/27/2026 - 07:55 AM EDT Accepted by SEC EDGAR 08/27/2026 - 07:54 AM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nechmad Yair

(Last)

(First)

(Middle)

C/O NAYAX LTD.

3 ARIK EINSTEIN

(Street)

HERZLIYA

(City)

(State)

(Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nayax Ltd. [ NYAX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CEO, Co Founder & Chairman

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	08/26/2026		M		75,000⁽³⁾	A	$33.7079⁽⁴⁾	7,168,442	D
Ordinary Shares	08/26/2026		M		75,000⁽³⁾	A	$33.7079⁽⁴⁾	7,243,442	D
Ordinary Shares	08/26/2026		M		70,000⁽³⁾	A	$33.7079⁽⁴⁾	7,313,442	D
Ordinary Shares	08/26/2026		M		15,605⁽³⁾	A	$33.7079⁽⁴⁾	7,329,047	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$33.7079⁽¹⁾	08/26/2026		M⁽²⁾			75,000	03/08/2022	03/08/2027	Ordinary Shares	75,000	$0	0	D
Stock Option (Right to Buy)	$33.7079⁽¹⁾	08/26/2026		M⁽²⁾			75,000	03/04/2025	03/04/2030	Ordinary Shares	75,000	$0	0	D
Stock Option (Right to Buy)	$33.7079⁽¹⁾	08/26/2026		M⁽²⁾			70,000	03/08/2022	03/08/2027	Ordinary Shares	70,000	$0	0	D
Stock Option (Right to Buy)	$33.7079⁽¹⁾	08/26/2026		M⁽²⁾			15,605	03/04/2025	03/04/2030	Ordinary Shares	15,605	$0	0	D

Explanation of Responses:

1. The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.

2. The options reported herein were exercised on the date reported, and the shares acquired upon exercise are reported in Table I .

3. The shares were acquired upon the exercise of stock options

4. The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.

	/s/ Meirav Shemesh on behalf of Oppenheimer Israel, as Attorney-in-fact	08/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR